Think Globally. Execute Locally.
Global execution.
Local market growth.
A one-stop solution for your international medical device commercialization. We grow medtech brands at a country level through regional leadership and a vetted distributor network.
- 75+
- Countries
- 100+
- Distributor partners
- 5
- Regions
- $2B
- Category created
Why MedTech Solutions Group
When MTSG represents your brand, it inherits a proven track record of launching products and growing brands.
Products marketed across 75+ countries — and counting.
A vetted global network that knows its local markets.
Regional leadership across EMEA, SE Asia, APAC, LatAm, and Canada.
The team established the Negative Pressure Wound Therapy market.
How we help
One partner, from strategy to country-level execution.
MedTech Solutions Group was founded in 2018 by an experienced team of healthcare executives with a track record of globally commercializing medical devices — technologies that improved patient outcomes, lowered healthcare costs, and in many cases redefined how care is delivered.
- ✓ Define your international commercialization objectives.
- ✓ Develop your international marketing, sales, and clinical strategies.
- ✓ Execute and manage your commercialization plan at a country level — existing brands or new technologies.
We grow brands at a country level
A network of professional distributor partners who know their markets and have a history of growing product portfolios.
Regional MTSG leaders work directly with distributor partners to grow the brands MTSG manages.
HQ leadership manages the overall execution of the commercialization plan for each client.
Our core strengths
Global strategy, regional leadership, clinical depth.
Experienced global team
- Results driven
- Local regional management
- Distributor partner network
- Country-requirements knowledge
Excellent clinical expertise
- Wound & skin care
- Critical care
- Surgical
Broad company experience
- Start-up
- Emerging
- Industry-leading
Established networks
- Clinical (KOL)
- Distributor
- Industry
- Business
- Investor
Proven global success
- Launching new products
- Turning around underperforming brands
- Education & training
- Clinical research
Varied industry experience
- Advanced wound & skin care
- NPWT
- Critical care
- Surgical
- Cardiovascular
Global leadership team
Regional executives who have launched and grown brands in their own markets.
Past President, CEO and board member of Spiracur; Vice Chairman of KCI USA where he led the launch of the VAC Therapy System; former Executive Chairman of Systagenix.
25+ years establishing and leading international commercialization for KCI, Systagenix, and Spiracur.
30+ years in wound care; recently Worldwide Head of Wound Care for Convatec; prior roles at BSN Medical, KCI, and Smith & Nephew.
20+ years developing the Latin America market for select medical products, including KCI's VAC Therapy.
30+ years in sales management, strategic marketing, and executive leadership at KCI Medical Canada and Hollister Ltd Canada.
20+ years in medical devices; marketing leadership at Acelity, Spiracur, Prescient Surgical, Medtronic, Kyphon, Abbott Vascular, and Synthes.
25+ years as an RN and educator in Tissue Viability and Wound Care; leadership roles at Healogics, Archimed, Healthy.io, and Bruin Biometrics.
Business analytics, data organization, and business development; supports executives across operations and growth.
Full leadership roster and final titles to be confirmed.
Current clients
You're in good company.
Track record across the team's careers: KCI · Systagenix · Spiracur · Convatec · Smith & Nephew · BSN Medical · Hollister · Acelity · Medtronic · Kerecis · NanoVibronix.
Need a one-stop solution for international commercialization?
Tell us about your brand and the markets you want to reach. A regional leader will follow up.
- Phone
- +1 210 474 0186
- Office
- 10 Dominion Dr. Suite 2205, San Antonio, TX 78257